Key Market Indicators
Canadian Vaccination Coverage is projected to hold steady at 91 percent for children aged one year old by 2028, reflecting no change from the 2023 rate. This consistency highlights a stable trend in the Canadian market since 1992. In terms of vaccine importation, Canada is expected to see a significant increase. Imports are projected to reach approximately $830 million by 2028, up from nearly $700 million in 2023. This represents a compound annual growth rate (CAGR) of 2.6 percent. Since 1994, the demand for vaccines in Canada has shown a robust annual growth of 7.1 percent. On the export front, Canadian vaccine exports are set to reach nearly $500 million by 2028, a modest rise from close to $490 million in 2023. This indicates a CAGR of 0.2 percent. However, since 1994, the Canadian supply of vaccines has decreased by 3 percent annually. In 2023, Canada ranked 10th globally in vaccine exports, with Germany surpassing it at the same value. Belgium, the United Kingdom, and France held the second, third, and fourth positions, respectively.
